Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia
- PMID: 1832073
- DOI: 10.1093/brain/114.4.1953
Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia
Abstract
Levels of iron, copper, zinc and manganese were measured by inductively coupled plasma spectroscopy in frozen postmortem brain tissue from patients with Parkinson's disease (PD), progressive supranuclear palsy (PSP), multiple system atrophy with strionigral degeneration (MSA), and Huntington's disease (HD) compared with control subjects. Total iron levels were found to be elevated in the areas of basal ganglia showing pathological change in these disorders. In particular, total iron content was increased in substantia nigra in PD, PSP and MSA, but not in HD. Total iron levels in the striatum (putamen and/or caudate nucleus) were increased in PSP, MSA and HD but not in PD. Total iron levels were decreased in the globus pallidus in PD. There were no consistent alterations of manganese levels in basal ganglia structures in any of the diseases studied. Copper levels were decreased in the substantia nigra in PD, and in the cerebellum in PSP, and were elevated in the putamen and possibly substantia nigra in HD. Zinc levels were only increased in PD, in substantia nigra and in caudate nucleus and lateral putamen. Levels of the iron binding protein ferritin were measured in the same patient groups using a radio-immunoassay technique. Increased iron levels in basal ganglia were generally associated with normal or elevated levels of ferritin immunoreactivity, for example, the substantia nigra in PSP and possibly MSA, and in putamen in MSA. The exception was PD where there was a generalized reduction in brain ferritin immunoreactivity, even in the substantia nigra. An increase in total iron content appears to be a response to neurodegeneration in affected basal ganglia regions in a number of movement disorders. However, only in PD was there an increased total iron level, decreased ferritin content, decreased copper content, and an increased zinc concentration in substantia nigra. These findings suggest an alteration of iron handling in the substantia nigra in PD. Depending on the form in which the excess iron load exists in nigra in PD, it may contribute to the neurodegenerative process.
Similar articles
-
Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. The Royal Kings and Queens Parkinson's Disease Research Group.Ann Neurol. 1992;32 Suppl:S94-100. doi: 10.1002/ana.410320716. Ann Neurol. 1992. PMID: 1510387 Review.
-
Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.Ann Neurol. 1994 Sep;36(3):348-55. doi: 10.1002/ana.410360305. Ann Neurol. 1994. PMID: 8080242
-
Topographical differences of brain iron deposition between progressive supranuclear palsy and parkinsonian variant multiple system atrophy.J Neurol Sci. 2013 Feb 15;325(1-2):29-35. doi: 10.1016/j.jns.2012.11.009. Epub 2012 Dec 20. J Neurol Sci. 2013. PMID: 23260321
-
Free-water imaging in Parkinson's disease and atypical parkinsonism.Brain. 2016 Feb;139(Pt 2):495-508. doi: 10.1093/brain/awv361. Epub 2015 Dec 24. Brain. 2016. PMID: 26705348 Free PMC article.
-
Brain monoamines in progressive supranuclear palsy--comparison with idiopathic Parkinson's disease.J Neural Transm Suppl. 1994;42:219-27. doi: 10.1007/978-3-7091-6641-3_17. J Neural Transm Suppl. 1994. PMID: 7964689 Review.
Cited by
-
Activation of Wnt/β-catenin pathway by exogenous Wnt1 protects SH-SY5Y cells against 6-hydroxydopamine toxicity.J Mol Neurosci. 2013 Jan;49(1):105-15. doi: 10.1007/s12031-012-9900-8. Epub 2012 Oct 11. J Mol Neurosci. 2013. PMID: 23065334
-
BFRnet: A deep learning-based MR background field removal method for QSM of the brain containing significant pathological susceptibility sources.Z Med Phys. 2023 Nov;33(4):578-590. doi: 10.1016/j.zemedi.2022.08.001. Epub 2022 Sep 2. Z Med Phys. 2023. PMID: 36064695 Free PMC article.
-
Loss of primary cilia and dopaminergic neuroprotection in pathogenic LRRK2-driven and idiopathic Parkinson's disease.Proc Natl Acad Sci U S A. 2024 Aug 6;121(32):e2402206121. doi: 10.1073/pnas.2402206121. Epub 2024 Aug 1. Proc Natl Acad Sci U S A. 2024. PMID: 39088390 Free PMC article.
-
Parkinson's disease.Postgrad Med J. 1992 Jul;68(801):538-43. doi: 10.1136/pgmj.68.801.538. Postgrad Med J. 1992. PMID: 1437950 Free PMC article. Review. No abstract available.
-
Subchronic administration of haloperidol influences the functional deficits of postnatal iron administration in mice.Neurotox Res. 2006 Oct;10(2):123-9. doi: 10.1007/BF03033241. Neurotox Res. 2006. PMID: 17062374
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous